Healthtech funding in H1 2011

European Healthtech startup funding raised during H1 2011.

In H1 2011, 40 European Healthtech companies closed 41 funding rounds and raised €305M in equity funding (excluding debt and grants), up 48.1% versus H1 2010. Denmark led by capital raised, and Enterprise Ireland was the most active investor. Data as of 6 Nov 2026.

Equity funding

€305M

+48.1% vs H1 2010 · excl. debt & grants

Funding rounds

+78.3% vs H1 2010

Companies

Top country

Denmark

Rank among sectors

17.0% of sector funding

Top-10 round share

82.9%

of disclosed capital

Rounds ≥ €100M

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jan	€30M	6
Feb	€140M	4
Mar	€18M	8
Apr	€30M	3
May	€44M	9
Jun	€46M	11

Top countries

by € raised

Data table

	Healthtech — top countries by capital, H1 2011
Denmark	€100M
UK	€72M
Switzerland	€28M
Israel	€27M
Sweden	€23M
Finland	€21M
Germany	€14M
France	€8.6M

Stage mix

by € raised

Data table

	Healthtech — stage mix, H1 2011
Series D+	€133M
Series B	€43M
Series A	€32M
Other	€30M
Series C	€27M
Growth/Late	€27M
Early VC	€8.4M
Seed	€3.3M
Grant	€1.7M

Exits & M&A

1 Acquisition

1 exit · €909M disclosed.

BioVex

Acquisition

Jan 2011

€909M

Top deals

largest disclosed rounds in H1 2011

Company	Stage	Date	Amount
Symphogen	Series D+	Feb 2011	€100M
CellNovo	Series B	Feb 2011	€35M
Oxford Nanopore Technologies	Series D+	Apr 2011	€28M
Anergis	Series A	Mar 2011	€14M
GenKyoTex	Series C	May 2011	€14M
BONESUPPORT	Growth/Late	Jun 2011	€13M
LifeBond	Series C	May 2011	€13M
Sapiens	Series A	Jun 2011	€13M
OrSense	Growth/Late	May 2011	€12M
Nexstim	Other	Jan 2011	€11M
InDex Pharmaceuticals	Other	Jan 2011	€8.3M
Mendor	Series B	Jun 2011	€8.1M
Impeto Medical	Other	Jan 2011	€6.1M
Cappella Medical Devices	Series D+	Feb 2011	€5.2M
Craneware	Early VC	Jun 2011	€4.2M

View all 41 Healthtech deals in H1 2011 →

Top investors

most active in H1 2011, by deal count

← All 2011 Healthtech funding